Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency

Kylie BR Belchamber,1 Eloise M Walker,1 Robert A Stockley,1 Elizabeth Sapey1,2 1Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; 2NIHR Clinical Research Facility Birmingham, University Hospitals Birmingham NHS Foundation Trust, Bir...

Full description

Bibliographic Details
Main Authors: Belchamber KBR, Walker EM, Stockley RA, Sapey E
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/monocytes-and-macrophages-in-alpha-1-antitrypsin-deficiency-peer-reviewed-article-COPD
id doaj-f0e3839a57844080be1a1341379066f6
record_format Article
spelling doaj-f0e3839a57844080be1a1341379066f62020-12-03T20:15:52ZengDove Medical PressInternational Journal of COPD1178-20052020-12-01Volume 153183319259971Monocytes and Macrophages in Alpha-1 Antitrypsin DeficiencyBelchamber KBRWalker EMStockley RASapey EKylie BR Belchamber,1 Eloise M Walker,1 Robert A Stockley,1 Elizabeth Sapey1,2 1Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; 2NIHR Clinical Research Facility Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UKCorrespondence: Kylie BR BelchamberBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UKEmail k.belchamber@bham.ac.ukAbstract: Alpha-1 antitrypsin deficiency (AATD) is a genetic condition characterised by low circulating levels of alpha-1 antitrypsin (AAT), a serine proteinase inhibitor. The most common deficiency variants are the S and Z mutations, which cause the accumulation of misfolded AAT in hepatocytes resulting in endoplasmic reticular stress and insufficient release of AAT into the circulation (< 11μmol/L). This leads to liver disease, as well as an increased risk of emphysema due to unopposed proteolytic activity of neutrophil-derived serine proteinases in the lungs. AATD has been traditionally viewed as an inflammatory disorder caused directly by a proteinase-antiproteinase imbalance in the lung, but increasing evidence suggests that low AAT levels may affect other cellular functions. Recently, AAT polymers have been identified in both monocytes and macrophages from AATD patients and evidence is building that these cells may also play a role in the development of AATD lung disease. Alveolar macrophages are phagocytic cells that are important in the lung immune response but are also implicated in driving inflammation. This review explores the potential implications of monocyte and macrophage involvement in non-liver AAT synthesis and the pathophysiology of AATD lung disease.Keywords: monocyte, macrophage, alpha-1 antitrypsin, alpha-1 antitrypsin deficiencyhttps://www.dovepress.com/monocytes-and-macrophages-in-alpha-1-antitrypsin-deficiency-peer-reviewed-article-COPDmonocyte macrophage alpha-1 antitrypsin alpha-1 antitrypsin deficiency
collection DOAJ
language English
format Article
sources DOAJ
author Belchamber KBR
Walker EM
Stockley RA
Sapey E
spellingShingle Belchamber KBR
Walker EM
Stockley RA
Sapey E
Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
International Journal of COPD
monocyte macrophage alpha-1 antitrypsin alpha-1 antitrypsin deficiency
author_facet Belchamber KBR
Walker EM
Stockley RA
Sapey E
author_sort Belchamber KBR
title Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
title_short Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
title_full Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
title_fullStr Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
title_full_unstemmed Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
title_sort monocytes and macrophages in alpha-1 antitrypsin deficiency
publisher Dove Medical Press
series International Journal of COPD
issn 1178-2005
publishDate 2020-12-01
description Kylie BR Belchamber,1 Eloise M Walker,1 Robert A Stockley,1 Elizabeth Sapey1,2 1Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; 2NIHR Clinical Research Facility Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UKCorrespondence: Kylie BR BelchamberBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UKEmail k.belchamber@bham.ac.ukAbstract: Alpha-1 antitrypsin deficiency (AATD) is a genetic condition characterised by low circulating levels of alpha-1 antitrypsin (AAT), a serine proteinase inhibitor. The most common deficiency variants are the S and Z mutations, which cause the accumulation of misfolded AAT in hepatocytes resulting in endoplasmic reticular stress and insufficient release of AAT into the circulation (< 11μmol/L). This leads to liver disease, as well as an increased risk of emphysema due to unopposed proteolytic activity of neutrophil-derived serine proteinases in the lungs. AATD has been traditionally viewed as an inflammatory disorder caused directly by a proteinase-antiproteinase imbalance in the lung, but increasing evidence suggests that low AAT levels may affect other cellular functions. Recently, AAT polymers have been identified in both monocytes and macrophages from AATD patients and evidence is building that these cells may also play a role in the development of AATD lung disease. Alveolar macrophages are phagocytic cells that are important in the lung immune response but are also implicated in driving inflammation. This review explores the potential implications of monocyte and macrophage involvement in non-liver AAT synthesis and the pathophysiology of AATD lung disease.Keywords: monocyte, macrophage, alpha-1 antitrypsin, alpha-1 antitrypsin deficiency
topic monocyte macrophage alpha-1 antitrypsin alpha-1 antitrypsin deficiency
url https://www.dovepress.com/monocytes-and-macrophages-in-alpha-1-antitrypsin-deficiency-peer-reviewed-article-COPD
work_keys_str_mv AT belchamberkbr monocytesandmacrophagesinalpha1antitrypsindeficiency
AT walkerem monocytesandmacrophagesinalpha1antitrypsindeficiency
AT stockleyra monocytesandmacrophagesinalpha1antitrypsindeficiency
AT sapeye monocytesandmacrophagesinalpha1antitrypsindeficiency
_version_ 1724401186188034048